iohexol has been researched along with Cancer of the Thyroid in 5 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Excerpt | Relevance | Reference |
---|---|---|
"There is concern about potential interference of iodinated contrast used in contrast-enhanced computerized tomography (CECT) with radioiodine therapy in differentiated thyroid carcinoma (DTC)." | 9.20 | Preoperative contrast-enhanced computerized tomography should not delay radioiodine ablation in differentiated thyroid carcinoma patients. ( Babu, S; Gambhir, S; Gupta, A; Mishra, A; Pradhan, PK; Sabaretnam, M, 2015) |
"There is concern about potential interference of iodinated contrast used in contrast-enhanced computerized tomography (CECT) with radioiodine therapy in differentiated thyroid carcinoma (DTC)." | 5.20 | Preoperative contrast-enhanced computerized tomography should not delay radioiodine ablation in differentiated thyroid carcinoma patients. ( Babu, S; Gambhir, S; Gupta, A; Mishra, A; Pradhan, PK; Sabaretnam, M, 2015) |
"Anaplastic thyroid carcinoma is rare but is one of the most aggressive malignancies." | 1.35 | Anaplastic thyroid carcinoma: computed tomographic differentiation from other thyroid masses. ( Chang, SK; Cho, SJ; Choi, CS; Kim, KH; Lee, JW; Rho, YS; Seo, YL; Yoon, DY; Yun, EJ, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rossfeld, KK | 1 |
Justiniano, SE | 1 |
Ding, H | 1 |
Gong, L | 1 |
Kothandaraman, S | 1 |
Sawant, D | 1 |
Saji, M | 1 |
Wright, CL | 1 |
Kirschner, LS | 1 |
Ringel, MD | 1 |
Tweedle, MF | 1 |
Phay, JE | 1 |
Yeom, JA | 1 |
Roh, J | 1 |
Jeong, YJ | 1 |
Lee, JC | 1 |
Kim, HY | 1 |
Suh, YJ | 1 |
Baik, SK | 1 |
Mishra, A | 1 |
Pradhan, PK | 1 |
Gambhir, S | 1 |
Sabaretnam, M | 1 |
Gupta, A | 1 |
Babu, S | 1 |
Choi, JS | 1 |
Kim, J | 1 |
Kwak, JY | 1 |
Kim, MJ | 1 |
Chang, HS | 1 |
Kim, EK | 1 |
Lee, JW | 1 |
Yoon, DY | 1 |
Choi, CS | 1 |
Chang, SK | 1 |
Yun, EJ | 1 |
Seo, YL | 1 |
Rho, YS | 1 |
Cho, SJ | 1 |
Kim, KH | 1 |
2 trials available for iohexol and Cancer of the Thyroid
Article | Year |
---|---|
Ultra-Low-Dose Neck CT With Low-Dose Contrast Material for Preoperative Staging of Thyroid Cancer: Image Quality and Diagnostic Performance.
Topics: Adult; Aged; Contrast Media; Female; Humans; Iohexol; Male; Middle Aged; Neoplasm Staging; Radiation | 2019 |
Preoperative contrast-enhanced computerized tomography should not delay radioiodine ablation in differentiated thyroid carcinoma patients.
Topics: Adult; Carcinoma; Contraindications; Contrast Media; Female; Humans; Iodine; Iodine Radioisotopes; I | 2015 |
3 other studies available for iohexol and Cancer of the Thyroid
Article | Year |
---|---|
Biological Evaluation of a Fluorescent-Imaging Agent for Medullary Thyroid Cancer in an Orthotopic Model.
Topics: Animals; Biopsy, Needle; Calcitonin; Carcinoma, Neuroendocrine; Disease Models, Animal; Fluorescent | 2017 |
Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT.
Topics: Adult; Aged; Carcinoma, Papillary; Chi-Square Distribution; Contrast Media; Female; Humans; Image In | 2009 |
Anaplastic thyroid carcinoma: computed tomographic differentiation from other thyroid masses.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anaplasia; Carcinoma; Contrast Media; Diagnosis, Differe | 2008 |